Fresenius Kabi
Marco Kammel is an experienced IT professional currently serving as Vice President and Head of Manufacturing IT at Fresenius Kabi since July 2022. Prior to this role, Marco held multiple positions including Director of IT-Transformation, Director of Supply Chain Execution, and Managing Consultant in different capacities at Fresenius Digital Technology from October 2013 to June 2022. Marco began working at Fresenius Kabi in 2016 as Senior Manager for Supply Chain Processes and IT-Applications, and earlier experience includes a position at Immel Datentechnik GmbH. Marco Kammel holds a Master of Science and Bachelor of Science in Business Informatics from Technische Hochschule Mittelhessen, and an IT system specialist degree from Immel Datentechnik GmbH.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.